Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Medicare and Social Security go-broke dates pushed up due to rising health care costs, new SSA law BY Associated Press Washington, D.C. UPDATED 5:08 PM ET Jun. 20, 2025 ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

Novo Nordisk plans to expand access to Wegovy through a collaboration with WeightWatchers, days after ending a partnership with telehealth firm Hims & Hers to sell the weight-loss drug.

CVS Health’s first quarter results reflected steady execution across its core businesses, with management highlighting ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. While Novo lost share to Eli Lilly's once-weekly Trulicity, Ozempic and Rybelsus ...

Novo Nordisk has ended its partnership with Hims & Hers Health Inc., citing “deceptive marketing” and the selling of ...

The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded ...